Research Report
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 14, 2014; 20(14): 4059-4065
Published online Apr 14, 2014. doi: 10.3748/wjg.v20.i14.4059
Figure 1
Figure 1 Disease-free survival. The 1-, 2-, and 3-year disease-free survival rates were 80.0%, 68.2%, and 60.0%, respectively, in the LLS; and 80.8%, 59.9%, and 39.6%, respectively, in the RFA group. The disease-free survival curve was better for the LLS group than for the RFA group (P = 0.012). LLS: Left lateral sectionectomy; RFA: Radiofrequency ablation.